Amit Sachdev

Insider Reports History

Entity
Individual
Location
C/O Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, MA
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amit Sachdev:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VERTEX PHARMACEUTICALS INC / MA EVP Chief Patient & Ext Af Off Common Stock 68.5K $32.8M $479.61 Feb 26, 2025 Direct
VERTEX PHARMACEUTICALS INC / MA EVP Chief Patient & Ext Af Off Common Stock 882 $419K $475.34 Feb 26, 2025 401(k)
Eiger BioPharmaceuticals, Inc. Director Common Stock 16K $4.76K $0.30 Mar 11, 2022 Direct
Eiger BioPharmaceuticals, Inc. Director Stock Option (Right to Buy) 28K Mar 1, 2023 Direct

Insider Reports Filed by Amit Sachdev

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 26, 2025 1 -$1.78M 4 Feb 28, 2025 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2025 1 -$1.19M 4 Feb 26, 2025 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 14, 2025 1 -$991K 4 Feb 19, 2025 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 12, 2025 1 $0 4 Feb 14, 2025 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2025 1 -$962K 4 Feb 12, 2025 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 4, 2025 2 $0 4 Feb 6, 2025 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Jun 5, 2024 1 $0 4 Jun 7, 2024 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA May 15, 2024 1 -$13.8K 4 May 17, 2024 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 23, 2024 2 -$2.34M 4 Feb 27, 2024 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 21, 2024 1 -$1.35M 4 Feb 23, 2024 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 16, 2024 3 -$4.38M 4 Feb 21, 2024 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 9, 2024 2 -$2.21M 4 Feb 13, 2024 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 6, 2024 3 $0 4 Feb 8, 2024 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 15, 2023 1 -$12.9K 4 Nov 17, 2023 EVP Chief Patient & Ext Af Off
VRTX VERTEX PHARMACEUTICALS INC / MA Aug 10, 2023 1 -$3.51M 4 Aug 14, 2023 EVP, Chief Patient Officer
EIGR Eiger BioPharmaceuticals, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2023 1 -$714K 4 Feb 28, 2023 EVP, Chief Patient Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2023 1 -$1.02M 4 Feb 22, 2023 EVP, Chief Patient Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2023 2 -$2.16M 4 Feb 14, 2023 EVP, Chief Patient Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2023 4 $0 4 Feb 3, 2023 EVP, Chief Patient Officer
EIGR Eiger BioPharmaceuticals, Inc. Mar 11, 2022 2 $0 4 Mar 11, 2022 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2022 1 -$1.68M 4 Feb 28, 2022 EVP, Chief Patient Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2022 1 -$813K 4 Feb 22, 2022 EVP, Chief Patient Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2022 1 -$592K 4 Feb 14, 2022 EVP, Chief Patient Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2022 3 $0 4 Feb 3, 2022 EVP, Chief Patient Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 15, 2021 2 -$9.55K 4 Nov 16, 2021 EVP, Chief Patient Officer
VRTX VERTEX PHARMACEUTICALS INC / MA May 17, 2021 3 -$9.74K 4 May 19, 2021 EVP, Chief Patient Officer